Skip to main content
ACBT logo

ACBT — Investor Relations & Filings

Ticker · 4148 ISIN · KYG0232P1072 TW Manufacturing
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-01-06 Fund Information / Fact…
Country TW Taiwan
Listing TW 4148

About ACBT

www.allcosmos.com

All Cosmos Bio-Tech Holding Corporation specializes in the application of microbiology to develop and manufacture high-performance bio-chemical fertilizers. Its core products utilize a proprietary formulation combining organic matter, beneficial microorganisms, and chemical elements to enhance soil health and productivity. The company also engages in waste reutilization, applying biotechnological processes to convert organic waste into sustainable resources, and conducts research and development of microbial strains for health care and pharmaceutical applications. By leveraging advanced microbial R&D, the organization provides solutions designed to reduce reliance on traditional chemical inputs and promote circular economy principles. Its activities focus on the synthesis of biological and chemical technologies to provide sustainable alternatives for soil management and resource recovery.

Recent filings

Filing Released Lang Actions
109年12月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief financial summary showing monthly and cumulative revenue figures for a company (全宇生技-KY) for the period 民國109年12月 (December 2020). It includes percentage changes and exchange rates but does not contain comprehensive financial statements or detailed analysis. The length is only 669 characters, indicating it is a short summary rather than a full report. There is no indication that this is an earnings release or an annual/interim report. The content fits best as a Fund Information / Factsheet (FS) or a brief financial summary. Given the short length and summary nature, FS is the most appropriate classification.
2021-01-06 Chinese
代子公司Arif Efektif Sdn.Bhd.公告董事辭任
Board/Management Information Classification · 100% confidence The document is a formal announcement from a listed company (4148 全宇生技-KY) regarding a change in the board of directors of its subsidiary Arif Efektif Sdn.Bhd. It details the resignation of directors and appointment of a new CEO, including reasons for the change and effective dates. There is no financial data, no report attached or referenced, and the content focuses solely on management changes. This fits the definition of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or certification, so it is not RPA or RNS.
2020-12-29 Chinese
109年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of insiders, including directors, managers, and other key personnel, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share transactions and holdings rather than financial results, management changes, or other corporate announcements. There is no indication of a full financial report, earnings release, or meeting materials. The document is a detailed insider shareholding disclosure, which corresponds to the category of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings, not just an announcement or summary.
2020-12-08 Chinese
109年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, managers, and major shareholders, with specific numbers of shares held, pledged shares, and related information. It is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is about 3,081 characters, which is sufficient for such a report. There is no indication that this is an announcement of a report or a certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-12-08 Chinese
109年12月法人說明會簡報 — 414820201204E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation containing company profile, operational overview, financial data for 2020 Q3 including income statements and balance sheets, growth and development plans, and product information. It includes forward-looking statements and a Q&A section, typical of investor presentations. The presence of detailed financial data and operational metrics supports that this is a comprehensive presentation aimed at investors rather than a formal regulatory filing like an annual or quarterly report. There is no indication that this is a transcript, audit report, or announcement of voting results. The length and content are consistent with an Investor Presentation (IP).
2020-12-04 Chinese
109年12月法人說明會簡報 — 414820201204M001.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a detailed presentation from All Cosmos Bio-Tech Holding Corporation covering company overview, operational status, and specifically includes a detailed financial report for the third quarter of 2020 (2020 Q3). It contains comprehensive financial statements such as consolidated income statements, balance sheets, and profitability metrics for the quarter and year-to-date periods. The presence of actual financial data and analysis for a period shorter than a full fiscal year (quarterly data) indicates this is an Interim / Quarterly Report. The document length is over 10,000 characters, and it is not merely an announcement or a certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2020-12-04 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.